How is VIP (Vasoactive Intestinal Peptide) administered?
This describes how VIP (Vasoactive Intestinal Peptide) is typically administered in clinical and research references, not a self-administration guide. The usual route is Intranasal (most common in clinical use), on a 4x daily intranasal schedule, generally over months in CIRS protocol. Specific dosing is individual and beyond general information, and human evidence for VIP (Vasoactive Intestinal Peptide) is limited.
Administration at a glance (reference data)
- Route: Intranasal (most common in clinical use)
- Schedule: 4x daily intranasal
- Cycle length: Months in CIRS protocol
- Half-life: ~2 minutes (rapid clearance)
References
- Vasoactive intestinal peptide (VIP) and inflammation, review — Delgado M & Ganea D, Amino Acids, 2013
- Research advances of vasoactive intestinal peptide in the pathogenesis of ulcerative colitis by regulating interleukin-10 expression in regulatory B cells — Sun X et al., World Journal of Gastroenterology, 2020
- Therapeutic Potential of Vasoactive Intestinal Peptide and its Derivative Stearyl-Norleucine-VIP in Inflammation-Induced Osteolysis — Eger M et al., Frontiers in Pharmacology, 2021
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on VIP (Vasoactive Intestinal Peptide)
Full VIP (Vasoactive Intestinal Peptide) breakdownVIP (Vasoactive Intestinal Peptide) what it's used forVIP (Vasoactive Intestinal Peptide) side effectsVIP (Vasoactive Intestinal Peptide) mistakes to avoidVIP (Vasoactive Intestinal Peptide) who should avoid itVIP (Vasoactive Intestinal Peptide) half-lifeVIP (Vasoactive Intestinal Peptide) how long to workVIP (Vasoactive Intestinal Peptide) legal statusVIP (Vasoactive Intestinal Peptide) how it worksAsk the AI Coach
Last updated 2026-06-15.